Deep residual learning for molecular force fields

X Xinyu Jiang M Mingan Chen (Drug Discovery and Design Center, State Key Laboratory of Drug Research, Shanghai Institute of Materia Medica, Chinese Academy of Sciences) C Chuanlong Zeng D Duanhua Cao (Drug Discovery and Design Center, State Key Laboratory of Drug Research, Shanghai Institute of Materia Medica, Chinese Academy of Sciences) J Jie Yu R Runze Zhang (Drug Discovery and Design Center, State Key Laboratory of Drug Research, Shanghai Institute of Materia Medica, Chinese Academy of Sciences) Z Zunyun Fu Z Zhehuan Fan (Drug Discovery and Design Center, State Key Laboratory of Drug Research, Shanghai Institute of Materia Medica, Chinese Academy of Sciences) J Jiacheng Xiong (Drug Discovery and Design Center, State Key Laboratory of Drug Research, Shanghai Institute of Materia Medica, Chinese Academy of Sciences) X Xutong Li X Xiaomin Luo D Dan Teng M Mingyue Zheng

Abstract

Abstract Accurate descriptions of interactions between atoms are essential for molecular simulations used to study biology and support drug discovery. Existing force fields often face a trade-off between physical reliability, computational efficiency, and accuracy across unfamiliar molecules. Here we show that Residual Learning Force Field, a hybrid machine learning force field, can reduce this trade-off by combining simple physics-based descriptions of bonded interactions with learned corrections for remaining energetic effects. The two components are trained together through a three-step strategy so that each contributes complementary information. In tests covering drug-like molecules, molecular dimers, torsional energy profiles, energy-minimum structures, and biomolecular simulations, Residual Learning Force Field gives accurate and stable predictions across diverse systems. These results suggest that combining physical constraints with data-driven corrections can provide a practical route toward more reliable and efficient molecular simulation for biological research and drug discovery.

Article Details

Volume / Issue Vol. 1, Issue 1
Published June 30, 2026
ISSN 2041-1723
Publisher Nature Portfolio

Journal Info

Nature Communications

Nature Portfolio

ISSN: 2041-1723 Open Access Life Sciences

Authors (13)

X

Xinyu Jiang

M

Mingan Chen

Drug Discovery and Design Center, State Key Laboratory of Drug Research, Shanghai Institute of Materia Medica, Chinese Academy of Sciences

C

Chuanlong Zeng

D

Duanhua Cao

Drug Discovery and Design Center, State Key Laboratory of Drug Research, Shanghai Institute of Materia Medica, Chinese Academy of Sciences

J

Jie Yu

R

Runze Zhang

Drug Discovery and Design Center, State Key Laboratory of Drug Research, Shanghai Institute of Materia Medica, Chinese Academy of Sciences

Z

Zunyun Fu

Z

Zhehuan Fan

Drug Discovery and Design Center, State Key Laboratory of Drug Research, Shanghai Institute of Materia Medica, Chinese Academy of Sciences

J

Jiacheng Xiong

Drug Discovery and Design Center, State Key Laboratory of Drug Research, Shanghai Institute of Materia Medica, Chinese Academy of Sciences

X

Xutong Li

X

Xiaomin Luo

D

Dan Teng

M

Mingyue Zheng